APA

Morinaga S., Nakamura Y., Atsumi Y., Murakawa M., Yamaoku K., Aoyama T., Kobayashi S., Ueno M., Morimoto M., Yokose T. & Miyagi Y. (20161114). Locked Nucleic Acid In Situ Hybridization Analysis of MicroRNA-21 Predicts Clinical Outcome in Patients After Resection for Pancreatic Cancer Treated with Adjuvant Gemcitabine Monotherapy. : Anticancer research.

Chicago

Morinaga Soichiro, Nakamura Yoshiyasu, Atsumi Yohei, Murakawa Masaaki, Yamaoku Koichiro, Aoyama Toru, Kobayashi Satoshi, Ueno Makoto, Morimoto Manabu, Yokose Tomoyuki and Miyagi Yohei. 20161114. Locked Nucleic Acid In Situ Hybridization Analysis of MicroRNA-21 Predicts Clinical Outcome in Patients After Resection for Pancreatic Cancer Treated with Adjuvant Gemcitabine Monotherapy. : Anticancer research.

Harvard

Morinaga S., Nakamura Y., Atsumi Y., Murakawa M., Yamaoku K., Aoyama T., Kobayashi S., Ueno M., Morimoto M., Yokose T. and Miyagi Y. (20161114). Locked Nucleic Acid In Situ Hybridization Analysis of MicroRNA-21 Predicts Clinical Outcome in Patients After Resection for Pancreatic Cancer Treated with Adjuvant Gemcitabine Monotherapy. : Anticancer research.

MLA

Morinaga Soichiro, Nakamura Yoshiyasu, Atsumi Yohei, Murakawa Masaaki, Yamaoku Koichiro, Aoyama Toru, Kobayashi Satoshi, Ueno Makoto, Morimoto Manabu, Yokose Tomoyuki and Miyagi Yohei. Locked Nucleic Acid In Situ Hybridization Analysis of MicroRNA-21 Predicts Clinical Outcome in Patients After Resection for Pancreatic Cancer Treated with Adjuvant Gemcitabine Monotherapy. : Anticancer research. 20161114.